Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients

INTRODUCTION: PREDICT is a prognostication tool that calculates the potential benefit of various postsurgical treatments on the overall survival (OS) of patients with nonmetastatic invasive breast cancer. Once patient, tumor, and treatment details have been entered, the tool will show the estimated...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaguirre, Karen, Kai, Masaya, Kubo, Makoto, Yamada, Mai, Kurata, Kanako, Kawaji, Hitomi, Kaneshiro, Kazuhisa, Harada, Yurina, Hayashi, Saori, Shimazaki, Akiko, Morisaki, Takafumi, Mori, Hitomi, Oda, Yoshinao, Chen, Sanmei, Moriyama, Taiki, Shimizu, Shuji, Nakamura, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940221/
https://www.ncbi.nlm.nih.gov/pubmed/33452761
http://dx.doi.org/10.1002/cam4.3713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940221/
https://www.ncbi.nlm.nih.gov/pubmed/33452761
http://dx.doi.org/10.1002/cam4.3713

Ejemplares similares